Xolair vs Dupixent: What Is the Difference?

Neither is better for everyone. Both are add-on treatments for moderate-to-severe asthma that is not controlled by inhalers. Xolair is used for allergic asthma with raised IgE and positive allergy tests. Dupixent is used for asthma with an eosinophilic pattern or asthma that depends on oral steroids. Specialists check IgE, blood eosinophils, allergy tests and other conditions you have before choosing.

Xolair is not FDA-approved for atopic dermatitis (eczema). Dupixent is, and it is one of the main biologics prescribed for moderate-to-severe eczema. People who have both eczema and another condition that Xolair treats, such as chronic hives or food allergy, should ask their specialist how to approach each condition.

Dupixent is not approved for food allergy. Xolair is the biologic approved to reduce allergic reactions, including anaphylaxis, from accidental exposure in IgE-mediated food allergy, used together with avoiding the food. Dupixent is approved for eosinophilic esophagitis, a different condition that can be triggered by foods.

Xolair has long been approved for chronic spontaneous urticaria that continues despite antihistamines. Dupixent has more recently been approved for chronic spontaneous urticaria in some patients as well. Antihistamines remain the first step for hives. If hives persist, a specialist will compare options based on your history, age and insurance coverage.

No. Both are monoclonal antibodies that block one specific pathway. They do not carry the bone, blood sugar and weight side effects of long-term oral steroids, and they may help some people reduce steroid use. Do not stop or taper any steroid on your own after starting a biologic; changes should be supervised by your doctor.

Xolair's common side effects include injection-site reactions, joint pain, headache and tiredness, and it carries a boxed warning for anaphylaxis. Dupixent's common side effects include injection-site reactions, conjunctivitis and other eye irritation, and cold sores. Seek emergency care for trouble breathing, throat swelling or fainting after any injection.

Both are injected under the skin every 2 or 4 weeks. Xolair doses for asthma, nasal polyps and food allergy depend on body weight and IgE level, while the hives dose is fixed. Dupixent starts with a larger first dose, then follows a schedule set by condition, age and weight. Your prescriber sets the exact plan.

Combining two biologics is not a standard, labeled approach, and insurers rarely cover both at once. Specialists occasionally consider it for people with several severe conditions, but that is an individual decision with careful monitoring. If you are on one and still have uncontrolled symptoms, discuss switching or adding other treatments with your specialist.

No. Allergy shots, or allergen immunotherapy, contain the allergens you react to in gradually increasing doses to retrain the immune system over years. Xolair and Dupixent block inflammatory molecules while you take them and do not desensitize you. Immunotherapy targets specific environmental allergens and can be an option alongside or instead of biologics, depending on your condition.

Usually, yes. Both are specialty drugs, and most insurers require documentation of your diagnosis, lab results such as IgE or eosinophil counts, and a history of trying standard treatments first. Your specialist's office typically handles the paperwork, and both manufacturers run support programs that may lower costs for eligible commercially insured patients.